Cancer

Rice’s Biotech Launch Pad to lead commercialization of bioelectrical implant treatment for obesity, type 2 diabetes

$34.9M ARPA-H project aims to disrupt therapies' market and radically improve treatment options HOUSTON, Oct. 2, 2024 /PRNewswire/ -- Rice…

1 year ago

Gut Microbiome Health Tech Innovator, Ixcela Launches Virtual Clinic to Ease Cancer Symptoms After Landmark Roper St. Francis Healthcare Pilot

Gut Microbiome Health Plays Critical Role Reducing Cancer Care Side Effects including Fatigue, Brain Fog, Nausea, Constipation, Sleep and Overall…

1 year ago

The Caris Precision Oncology Alliance Welcomes UVA Cancer Center

UVA Cancer Center joins the extensive network of leading cancer institutions committed to improving patient outcomes through innovations in precision…

1 year ago

Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments

ATLANTA, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet…

1 year ago

PDS Biotech Announces 36-Month Overall Survival Rate of 84.4% in Locally Advanced Cervical Cancer Patients Treated with Versamune® HPV and Chemoradiation

100% 36-month overall survival (OS) and progression-free survival (PFS) rates in patients fully treated with Versamune® HPV combined with chemoradiation (N=8)88%…

1 year ago

Rudolph E. Tanzi, Co-Director of MassGeneral Institute for Neurodegenerative Disease, Chairs Cognos Neurodegenerative Scientific and Clinical Advisory Board

INGLEWOOD, California, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Cognos Therapeutics, a private hi-tech medical technology company focused on the development…

1 year ago

Verrica Pharmaceuticals Announces Restructuring of Commercial Organization

- Company significantly reduces cost structure with a realigned sales, marketing and operational infrastructure - Sales and marketing efforts to…

1 year ago

Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer

Glioblastoma study achieves milestone with successful dose escalation, setting stage for Phase 2MILAN and NEW YORK, Oct. 02, 2024 (GLOBE…

1 year ago

Curve Therapeutics further strengthens leadership team with the appointment of Andre Hoekema as new Chair of Board

Dr Hoekema brings over four decades of successful biotech and life science leadershipDr Cora Griffin appointed to head up business…

1 year ago